A Randomized Study Of The Effect Of Exemestane (Aromasin) Versus Placebo On Breast Density In Postmenopausal Women At Increased Risk For Development Of Breast Cancer.

Trial Profile

A Randomized Study Of The Effect Of Exemestane (Aromasin) Versus Placebo On Breast Density In Postmenopausal Women At Increased Risk For Development Of Breast Cancer.

Completed
Phase of Trial: Phase II/III

Latest Information Update: 28 Mar 2016

At a glance

  • Drugs Exemestane (Primary)
  • Indications Breast cancer
  • Focus Pharmacodynamics
  • Most Recent Events

    • 21 Sep 2013 Additional lead trial centre added as reported by ClinicalTrials.gov.
    • 21 Sep 2013 Additional lead trial centre added as reported by ClinicalTrials.gov.
    • 18 Mar 2010 Actual end date (Feb 2009) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top